A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables

BACKGROUND: Early biomarkers are helpful for predicting clinical endpoints and for evaluating efficacy in clinical trials even if the biomarker cannot replace clinical outcome as a surrogate. The building and evaluation of an association model between biomarkers and clinical outcomes are two equally...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhiwei, Song, Yang, Shou, Qiong, Xia, Jielai, Wang, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307375/
https://www.ncbi.nlm.nih.gov/pubmed/25528466
http://dx.doi.org/10.1186/1745-6215-15-500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307375/
https://www.ncbi.nlm.nih.gov/pubmed/25528466
http://dx.doi.org/10.1186/1745-6215-15-500

Ejemplares similares